ADVANCED TRANSFUSION MEDICINE RESEARCH FOUNDATION

Active

ADVANCED TRANSFUSION MEDICINE RESEARCH FOUNDATION having CIN U19129GJ1997NPL032264 is 28 years , 1 month & 6 days old Public Indian Company incorporated on 06 May 1997. It is classified as Non-government company and is registered at ROC Ahmedabad. Its authorized share capital is Rs. 20,000,000 and its paid up capital is Rs. 5,025,000. It's NIC code is 19129 (which is part of its CIN).

As per the NIC code, it is involved in . ADVANCED TRANSFUSION MEDICINE RESEARCH FOUNDATION Annual General Meeting (AGM) was last held on N/A and as per records from Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 09-30-2023. Directors of ADVANCED TRANSFUSION MEDICINE RESEARCH FOUNDATION are Mahesh Tarachand Mohatta and Urmish Hasmukh Chudgar.

ADVANCED TRANSFUSION MEDICINE RESEARCH FOUNDATION ' Corporate Identification Number (CIN) is U19129GJ1997NPL032264 and its registration number is 032264. Users may contact ADVANCED TRANSFUSION MEDICINE RESEARCH FOUNDATION on its Email address - manoj_nair@intaspharma.com Registered address of ADVANCED TRANSFUSION MEDICINE RESEARCH FOUNDATION is B/H JIVRAJ MAHETA HOSPITALVASNA,AHMEDABAD,Gujarat,India-380007. Current status of ADVANCED TRANSFUSION MEDICINE RESEARCH FOUNDATION is - Active.

Key Indicators

Authorised Capital

20,000,000

as on 12/06/2025

Paid Up Capital

5,025,000

as on 12/06/2025

Company Age

28 Year, 1 Months

Last Filing with ROC

1 Year, 8 Months

CIN	U19129GJ1997NPL032264
Company Status	Active
Registration Number	032264
Date of Incorporation	05/06/1997
RoC	ROC Ahmedabad
Company Age	28 years & 44 days
Authorized Capital	₹ 20000000
Paid-up capital	₹ 5025000
Company Category	Company limited by shares
Company Sub-Category	Non-government company
Class of company	Public
Activity
Listing status	Unlisted
Date of Last Annual General Meeting	31-03-2023
Date of Latest Balance Sheet	31-03-2023

Contact

Email ID	manoj_nair@intaspharma.com
Address	B/H JIVRAJ MAHETA HOSPITALVASNA AHMEDABAD Gujarat India 380007
Website	intaspharma.com
Contact Number	+91*******

Location on Map

Director

Designation	Name	Date OF Appointment	DIN	PAN	Tenure
Director	JWALANT SURESHBHAI SHAH	05/13/2022	02644030	*****8903C	3 years
Director	URMISH HASMUKH CHUDGAR	07/05/2024	00096080	*****1733G	0 years
Director	MAHESH TARACHAND MOHATTA	03/28/2008	00096131	*****9575H	17 years

Companies connected through Directors

Name	Status	Paid Up Capital	Common Directors	Address
SIMIRA UNIPATH DIAGNOSTICS PRIVATE LIMITED	Active	1,53,850.00	1	Maharashtra
UNIPATH SPECIALTY LABORATORY LIMITED	Active	22,76,00,000.00	2	Gujarat
ASTRON PACKAGING LIMITED	Active	2,94,71,410.00	2	Gujarat

Charges on assets

ABN AMRO BANK NV

No. of Loans: 5

Total Amount: 13,009,599.00 cr

CORPORATION BANK

No. of Loans: 1

Total Amount: 7,500,000.00 cr

UTI BANK LTD

No. of Loans: 1

Total Amount: 30,000,000.00 cr

TECHNOLOGY INFORMATION; FORECASTING & ASSESSMENT COUNCIL

No. of Loans: 1

Total Amount: 7,500,000.00 cr

SIEMENS FINANCIAL SERVICES PRIVATE LIMITED

No. of Loans: 1

Total Amount: 1,185,000.00 cr

Charge Holder	Branch	Amount	Date of creation	Modification	Satisfaction	Status
ABN AMRO BANK NV	DLF CYBER CITY , SECTOR 25A	1,600,000	07 Nov, 2007	-	22 Jan, 2013	Closed
CORPORATION BANK	ASHRAM ROAD	7,500,000	28 Sep, 2001	04 Jan, 2005	08 Apr, 2016	Closed
UTI BANK LTD	ASHRAM ROAD	30,000,000	01 Oct, 2003	-	19 Jul, 2007	Closed
ABN AMRO BANK NV	DLF CYBER CITY , SECTOR 25A	1,129,934	01 Nov, 2007	-	11 Jan, 2013	Closed
TECHNOLOGY INFORMATION; FORECASTING & ASSESSMENT COUNCIL	NEW MEHRAULI ROAD	7,500,000	14 Aug, 2001	-	05 Sep, 2012	Closed
SIEMENS FINANCIAL SERVICES PRIVATE LIMITED	WORLI	1,185,000	21 Dec, 2012	-	07 Mar, 2016	Closed
ABN AMRO BANK NV	DLF CYBER CITY , SECTOR 25A	3,428,165	04 Aug, 2007	-	11 Jan, 2013	Closed
ABN AMRO BANK NV	DLF CYBER CITY , SECTOR 25A	2,054,500	20 Jul, 2007	-	18 Mar, 2011	Closed
ABN AMRO BANK NV	DLF CYBER CITY , SECTOR 25A	4,797,000	07 Jul, 2007	-	08 Apr, 2011	Closed

Registered Details

CIN

U19129GJ1997NPL032264

PAN

U19129GJ1997NPL032264

Incorporation

17 years , 2 month

Company Email

manoj_nair@intaspharma.com

Paid up Capital

₹ 5,025,000

Authorised Capital

₹ 20,000,000

Type

Public Non-government company

* There is the date provided by MCA, but availability for this year is not guaranteed.

Key Metrics

** All rupee values in INR crores. Based on March 2024 numbers.

Sales

9.29%

₹ 0

EBITDA

29%

₹ 0

Net Profit

29%

₹ 0

Networth

29%

₹ 0

Borrowings

9.29%

₹ 0

Assets

9.29%

₹ 0

Gross Margin

9.29%

₹ 0

Operating Margin

29%

₹ 0

Net Profit Margin

29%

₹ 0

Return on Equity

29%

₹ 135,987.4

ROCE

9.29%

₹ 140,987.4

Debt to Equity

9.29%

₹ 0

Financial Highlights

** All numbers in INR crores

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales
Operating profit
Net profit
Gross margin
Operating margin
Net margin
Networth
Borrowings
Assets
Debt to equity
Current ratio
ROE
Days payable
WC days

Balance Sheet

**** All numbers in INR crores

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
EQUITY AND LIABILITIES
(1) Shareholders‘ funds +
(a) Share capita
(b) Reserves and surplus
(c) Money received against share warrants
(2) Share application money pending allotment
(3) Non-current liabilities +
(a) Long-term borrowings
(b) Deferred tax liabilities (Net)
(c) Other Long-term liabilities
(d) Long-term provisions
(4) Current liabilities +
(a) Short-term borrowings
(b) Trade payables
(A) total outstanding dues of micro enterprises and small enterprises; and
(B) total outstanding dues of creditors other than micro enterprises and small enterprises.
(c) Other current liabilities
(d) Short-term provisions
Total
ASSETS
Non-current assets +
(a) [Property, Plant and Equipment]
(i) Tangible assets
(ii) Intangible assets
(iii)Capital work-in-progress
(iv) Intangible assets under development
(b) Non-current investments
(c) Deferred tax assets (net)
(d) Long-term loans and advances
(e) Other non-current assets
(2) Current assets +
(a) Current investments
(b) Inventories
(c) Trade receivables
(d) Cash and cash equivalents
(e) Short-term loans and advances
(f) Other current assets
Total assets

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
EQUITY AND LIABILITIES
(1) Shareholders‘ funds +
(a) Share capita
(b) Reserves and surplus
(c) Money received against share warrants
(2) Share application money pending allotment
(3) Non-current liabilities +
(a) Long-term borrowings
(b) Deferred tax liabilities (Net)
(c) Other Long-term liabilities
(d) Long-term provisions
(4) Current liabilities +
(a) Short-term borrowings
(b) Trade payables
(A) total outstanding dues of micro enterprises and small enterprises; and
(B) total outstanding dues of creditors other than micro enterprises and small enterprises.
(c) Other current liabilities
(d) Short-term provisions
Total
ASSETS
Non-current assets +
(a) [Property, Plant and Equipment]
(i) Tangible assets
(ii) Intangible assets
(iii)Capital work-in-progress
(iv) Intangible assets under development
(b) Non-current investments
(c) Deferred tax assets (net)
(d) Long-term loans and advances
(e) Other non-current assets
(2) Current assets +
(a) Current investments
(b) Inventories
(c) Trade receivables
(d) Cash and cash equivalents
(e) Short-term loans and advances
(f) Other current assets
Total assets

Profit & Loss

**** All numbers in INR crores

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
I.Revenue from operations
II. Other income
III.Total Revenue (I + II)
IV.Expenses +
(1)Cost of materials consumed
(2)Purchases of Stock-in-Trade
(3)Changes in inventories of finished goods work-in-progress and
(4)Stock-in-Trade
(5)Employee benefits expense
(6)Finance costs
(7)Depreciation and amortisation expense
(8)Other expenses
(9)Total expenses
VProfit before exceptional and extraordinary items and tax (III - IV)
VIExceptional items
VII.Profit before extraordinary items and tax (V - VI)
VIII.Extraordinary items
IX.Profit before tax (VII- VIII)
X. Tax expense: +
(1)Current tax
(2)Deferred tax
XI.Profit (Loss) for the period from continuing operations (VII-VIII)
XII.Profit/(loss) from discontinuing operations
XIII.Tax expense of discontinuing operations
XIV.Profit/(loss) from Discontinuing operations (after tax) (XII-XIII)
XV.Profit (Loss) for the period (XI + XIV)
XVI.Earnings per equity share: +
(1) Basic
(2)Diluted

Precentage of total incomex
Sales +
Sales growth %
Expenses +
Cost of services
Employee benefits expense
Other costs
Operating profit +
Operating margin %
Other income
Interest
Depreciation
Exceptional items
Profit before tax
Tax
Profit - disc. ops
Net profit
Net margin %

Ratio

** All numbers in INR crores

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Solvency +	0.00	0.00	0.00	0.00	0.00
Total Debt/Equity	0.00	0.00	0.00	0.00	0.00
Net Debt/Equity	0.00	0.00	0.00	0.00	0.00
Total Debt/Assets	0.00	0.00	0.00	0.00	0.00
Total Assets/Equity	0.00	0.00	0.00	0.00	0.00
Liquidity +	0.00	0.00	0.00	0.00	0.00
Current Ratio	0.00	0.00	0.00	0.00	0.00
Quick Ratio	0.00	0.00	0.00	0.00	0.00
Interest Coverage	0.00	0.00	0.00	0.00	0.00
Performance	0.00	0.00	0.00	0.00	0.00
Gross Margin	0.00	0.00	0.00	0.00	0.00
Operating Margin	0.00	0.00	0.00	0.00	0.00
Net Margin	0.00	0.00	0.00	0.00	0.00
Return +	0.00	0.00	0.00	0.00	0.00
Return on Equity	0.00	0.00	0.00	0.00	0.00
Pre-tax ROCE	0.00	0.00	0.00	0.00	0.00
Return on Assets	0.00	0.00	0.00	0.00	0.00
Pre-tax ROIC	0.00	0.00	0.00	0.00	0.00
Efficiency +	0.00	0.00	0.00	0.00	0.00
Days Payable	0.00	0.00	0.00	0.00	0.00
Days Inventory	0.00	0.00	0.00	0.00	0.00
Days Receivable	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00
Total Asset Turnover	0.00	0.00	0.00	0.00	0.00
Working Capital	0.00	0.00	0.00	0.00	0.00
Cash Conversion Cycle	0.00	0.00	0.00	0.00	0.00
Working Capital Days	0.00	0.00	0.00	0.00	0.00

Subsidiaries, Associate Companies & Join Ventures of Advanced Transfusion Medicine Research Foundation

Company Identifier	Name	Percentage of Shares Held

Fund Raising Activity of Advanced Transfusion Medicine Research Foundation

Date of Allotment	Securities Alloted	Terms	Number of Securities	Nominal Amount	Premium Amount Due & Payable	Premium Amount Paid	Total Discount	Amount to be Paid on Calls (Excluding Premium)	Attachments

Board Meetings of Advanced Transfusion Medicine Research Foundation

Date of Filing	Date of Dispatch of Notice	Date of Passing Resolution	Section (Companies Act 2013)	Section (Companies Act 1956)	Subject Matter of Resolution	Resolution Agreed By	Resolution Type	Additional Documents

Auditors of Advanced Transfusion Medicine Research Foundation

Financial Year	Name of Auditor or Firm	PAN of Auditor or Firm	Membership Number / Registration Number	Name of Auditor Signing Report	Membership Number of Auditor Signing Report

Outstanding Payments to Micro & Small Enterprises

Filing Type	As On	Amount Due to MSME	Current Liabilities	Ratio to Current Liabilities	Reasons for Delay

Investor Complaints & Serious Complaints About Advanced Transfusion Medicine Research Foundation

Director Complain

Date	DIN	Cessation Date	Cessation Reason	Complaint

Serious Complaints

Date	Complaint	Other

Investor Complaints & Other Complaints

Date	Complaint Type	Complaint Sub Type	Particulars of Secutiries	Period	Complaint	Other Details

Prosecution Details of Advanced Transfusion Medicine Research Foundation

S.No.	Defaulting Entities	Court Name	Prosecution Section	Date of Order	Status

FAQs- Advanced Transfusion Medicine Research Foundation

What is ADVANCED TRANSFUSION MEDICINE RESEARCH FOUNDATION ?

ADVANCED TRANSFUSION MEDICINE RESEARCH FOUNDATION having CIN U19129GJ1997NPL032264 is 17 years , 2 month old Public Indian Company incorporated with MCA on 28 Mar 2008. ADVANCED TRANSFUSION MEDICINE RESEARCH FOUNDATION is listed in the class of Public Indian Company and classified as Non-government company. This company is registered at Registrar of Companies(ROC), ROC Ahmedabad with an Authorized Share Capital of 20,000,000 and paid-up capital is 5,025,000.

What is the CIN of ADVANCED TRANSFUSION MEDICINE RESEARCH FOUNDATION?

CIN of ADVANCED TRANSFUSION MEDICINE RESEARCH FOUNDATION is U19129GJ1997NPL032264.

Where is ADVANCED TRANSFUSION MEDICINE RESEARCH FOUNDATION located?

Address of ADVANCED TRANSFUSION MEDICINE RESEARCH FOUNDATION is B/h jivraj maheta hospitalvasna,ahmedabad,gujarat,india-380007,.

Who are the directors of ADVANCED TRANSFUSION MEDICINE RESEARCH FOUNDATION ?

The company has 5 directors/key management personnel Jwalant Shah,urmish Chudgar,jwalant Shah,mahesh Mohatta,urmish Chudgar,

What is the contact details of ADVANCED TRANSFUSION MEDICINE RESEARCH FOUNDATION ?

Email : manoj_nair@intaspharma.com
Address : B/H JIVRAJ MAHETA HOSPITALVASNA AHMEDABAD Gujarat India 380007

What does ADVANCED TRANSFUSION MEDICINE RESEARCH FOUNDATION do?

ADVANCED TRANSFUSION MEDICINE RESEARCH FOUNDATION is involved in activities such as Computer programming, consultancy and related activities

Popular Services

Spice Board registration APEDA Registration Importer Exporter Code Registration AD Code Registration ESI Registration FSSAI Registration FCRA Registration FCRA Registration for Trusts FCRA Registration for Societies FCRA Registration for Section 8 Company Import Export Code Import Export Code Process NSIC Registration Private Limited Company Limited Liability Partnership Partnership Firm One Person Company Startup India Registration PF Registration Director KYC Auditor's Appointment Director's Appointment Net worth Certificate Labour License LLP Annual Compliance Filing